John Jesitus is a medical writer based in Westminster, CO.
Allergic contact dermatitis: Pediatric patch tests mirror those of adults
September 15th 2009National Report - Children with allergic contact dermatitis frequently react to the same allergens as adults with this condition do, according to a recent multi-center study conducted at the University of Miami and the University of Pennsylvania that calls for increased patch testing in children, especially those with chronic dermatitis.
Weight-based dosing: Extended-release minocycline efficient, predictable
September 11th 2009Las Vegas - Weight-based dosing with extended-release (ER) minocycline tablets allows patients with acne to achieve efficacy equivalent to that of 2 mg/kg or 3 mg/kg of body weight daily with just 1 mg/kg daily, says James Q. Del Rosso, D.O., dermatology residency director, Valley Hospital Medical Center, Las Vegas.
Skin protection: New barrier cream protects without irritating
September 11th 2009Las Vegas - A skin barrier protection cream (Tetrix, Coria Laboratories) appears to reduce exposure to skin allergens and irritants and decrease symptoms of eczematous dermatitis, according to James Q. Del Rosso, D.O., dermatology residency director, Valley Hospital Medical Center, Las Vegas.
Seborrheic dermatitis: Ketoconazole foam most effective against Malassezia
September 2nd 2009Houston - Recent research makes clear that the yeast genus Malassezia plays a role in the etiology of seborrheic dermatitis and several other common cutaneous disorders - and that ketoconazole is the most effective treatment for Malassezia overgrowth, an expert says.
Prepping for a pandemic: Be ready for widespread flu - or any other emergency
September 1st 2009While the H1N1 or swine flu virus pandemic hasn't proven particularly deadly to date, sources say it should remind dermatologists to remain vigilant and prepared for myriad threats, from infectious agents to natural disasters, bioterrorism and power outages
Fear not: Botox safety concerns overstated, expert says
August 26th 2009Las Vegas - Although some recent animal research and human case reports have spurred concerns regarding the safety of Botox Cosmetic (botulinum toxin A, Allergan), one of the product's pioneers says that Botox remains safe when used as directed for cosmetic indications.
Laser update: Fractionated devices, wavelength combinations drive surgery segment
August 14th 2009Washington - Over the next five years, fractionated lasers and combined-wavelength treatments will continue to lead growth in the dermatologic laser surgery segment, according to a leading dermatologic laser surgeon.
Exit Accutane: Derms' reactions mixed as Roche pulls long-standing remedy
August 1st 2009Dermatologists' reactions to Hoffman-La Roche's decision to discontinue its once-popular acne drug Accutane (isotretinoin) run the gamut. Some express disappointment or surprise; others marvel that the drug survived as long as it did.
Joint session: ASCDAS, ASDS pair up; weak economy encourages collaboration, leaders say
February 1st 2009National report - The American Society of Cosmetic Dermatology and Aesthetic Surgery (ASCDAS) and the American Society for Dermatologic Surgery (ASDS) will host a combined meeting Oct. 1-4, 2009, in Phoenix, the organizations announced in December.
Facing forward: Cleveland Clinic performs first U.S. transplant; ethical concerns remain
February 1st 2009Cleveland - Plastic surgeons are welcoming the news of the world's first near-total face transplant - and the first such operation in the United States - performed in late 2008 at the Cleveland Clinic.
Down but not out: Aesthetic market tightens with bankruptcies, buyouts
February 1st 2009National report - The bankruptcy of Artes Medical, maker of the permanent facial filler ArteFill, will make it harder for permanent fillers to enter the U.S. market in the future, analysts say - although one such product, Contura's Aquamid, will likely seek Food and Drug Administration (FDA) approval in 2009.
Psoriasis & SCC: Adalimumab, acitretin control PUVA-related side effects
December 1st 2008The dramatic improvement of a psoriasis patient who had developed squamous cell carcinoma secondary to PUVA treatment illustrates that adalimumab and acitretin work synergistically, a physician familiar with the case says.
Evaluating fellows: Procedural derm, dermatopathology programs lacking
December 1st 2008National report - When it comes to performing required semiannual evaluations of fellows, both dermatopathology fellowship programs and procedural dermatology fellowship programs fall short, according to a recent study.
Stamp of approval: ACGME recognition validates procedural fellowships
December 1st 2008National report - Recognition from the Accreditation Council for Graduate Medical Education (ACGME) brings structure and standardization to surgical dermatology training, says a Mohs surgeon who has pushed for procedural certification.